Application Sponsors
ANDA 211021 | JIANGSU HANSOH PHARM | |
Marketing Status
Application Products
001 | INJECTABLE;SUBCUTANEOUS | EQ 30MG BASE/3ML (EQ 10MG BASE/ML) | 0 | ICATIBANT ACETATE | ICATIBANT ACETATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2020-03-09 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2020-09-25 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
JIANGSU HANSOH PHARM
cder:Array
(
[0] => Array
(
[ApplNo] => 211021
[companyName] => JIANGSU HANSOH PHARM
[docInserts] => ["",""]
[products] => [{"drugName":"ICATIBANT ACETATE","activeIngredients":"ICATIBANT ACETATE","strength":"EQ 30MG BASE\/3ML (EQ 10MG BASE\/ML)","dosageForm":"INJECTABLE;SUBCUTANEOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"03\/09\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] => [{"actionDate":"09\/25\/2020","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2020-09-25
)
)